**4. Current treatment for obesity management and its effects**

Anti-obesity drugs have been studied profoundly for decades [11–13]. The need for adjunctive therapies for weight loss has accelerated the progress in the pharmaceutical industry worldwide. Weight loss drugs may appear to be a solution to obesity. However, possible side effects or adverse drug reactions are always a big public health concern and also a major barrier to the development of new drug products. Some of the antiobesity drugs commercially available are orlistat, lorcaserin, sibutramine, rimonabant, metformin, exenatide, pramlintide etc. These drugs have a wide variety of severe side-effects including development of cardiovascular problems, restlessness, insomnia, faulty bowel movements, pain in stomach, psychiatric problems etc. Ideally anti-obesity agent would be such as to produce weight loss which can be retained, but with minimal side effects. Medication for short term weight management or selected medications used off label to promote weight loss mentioned in (**Table 2**) and Medication for long term weight management are listed in (**Table 3**).


### **Table 2.**

*Medication for short term weight management or selected medications used off label to promote weight loss.*


